Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: the Gruppo Italiano per lo Studio dei Linfomi Experience.
P. Gobbi(Istituti di Ricovero e Cura a Carattere Scientifico), E Ascari(Institute for Chemical and Physical Processes), Antonio La Sala(Casa Sollievo della Sofferenza), Massimo Federico(University of Modena and Reggio Emilia), Carla Pieresca(Policlinico San Matteo Fondazione), Raffaella Bertè, Antonio Frassoldati(Italian Oncology Group of Clinical Research), M Carotenuto(Policlinico Universitario di Catania), Nicola Di Renzo(Presidio Ospedaliero), V. Silingardi(Azienda Ospedaliero-Universitaria di Modena), Paolo Avanzini(Santa Maria Nuova Hospital)
Cited by 26
Related Papers
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
|Blood|2011|431
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
|Journal of Clinical Oncology|2012|368